Ginkgo Bioworks Holdings (DNA) Interest Coverage Ratio (2020 - 2024)
Ginkgo Bioworks Holdings (DNA) reported Interest Coverage Ratio of 3.3 for Q4 2024, up 18.4% on a YoY basis from 2.79 in Q1 2024, and down 155.35% quarter-over-quarter from 5.97 in Q3 2024.
Ginkgo Bioworks Holdings (DNA) Interest Coverage Ratio (2020 - 2024) Analysis & Trends
Ginkgo Bioworks Holdings has reported Interest Coverage Ratio for 4 years, with the latest figure at 3.3 in Q4 2024.
- For the quarter ending Q4 2024, Interest Coverage Ratio rose 18.4% year-over-year to 3.3; the trailing twelve-month figure through Sep 2025 stood at 10.84 (up 58.21% YoY), and the FY2024 full-year result was 5954.86, up 35.93% from the prior year.
- Interest Coverage Ratio for Q4 2024 stood at 3.3, down from 5.97 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 21.62 in Q2 2024, with the low at 3057.6 in Q4 2021.
- Historically, Interest Coverage Ratio has averaged 319.94 across 4 years, with a median of 3.68 in 2023.
- Annual changes were most pronounced in 2021 — Interest Coverage Ratio tumbled 3127.85% — and 2024, when it soared 68.45%.
- Ginkgo Bioworks Holdings' Interest Coverage Ratio stood at 94.73 in 2020, then plunged by 3127.85% to 3057.6 in 2021, then surged by 99.87% to 4.05 in 2023, then gained by 18.4% to 3.3 in 2024.
- The last three Interest Coverage Ratio figures came in at 3.3 (Q4 2024), 5.97 (Q3 2024), and 21.62 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -258.33 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 11.79 |
| 10 | Ginkgo Bioworks Holdings | 480.68 Mn | 480.68 Mn | 16.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -3.30 |
| Sep 30, 2024 | 5.97 |
| Jun 30, 2024 | 21.62 |
| Dec 31, 2023 | -4.05 |
| Sep 30, 2023 | 19.07 |
| Jun 30, 2023 | 12.83 |
| Dec 31, 2021 | -3,057.60 |
| Sep 30, 2021 | -41.10 |
| Dec 31, 2020 | -94.73 |
| Sep 30, 2020 | -58.13 |